title: Management of the elderly patients with inflammatory bowel disease: practical considerations.
abstract: The aging U.S. population will approach 20% of the total population by 2030. The number of older patients with inflammatory bowel disease is anticipated to increase accordingly bringing the burden of multiple comorbidities, polypharmacy with drug interactions, the aging immune system, and extended social and financial issues to overall management of an already challenging management of these patients. Each of these concerns is measured by the metric of distinguishing the "fit versus frail" elderly and will be discussed in this review with an emphasis on a practical guide to therapy.
authors.affiliation: New York University School of Medicine, New York City, New York, USA. seymourkatz.md@gmail.com
authors.forename: Seymour
authors.initials: S
authors.lastname: Katz
authors.forename: Christina
authors.initials: C
authors.lastname: Surawicz
authors.forename: Darrell S
authors.initials: DS
authors.lastname: Pardi
mesh_terms: D000368:Aged; D000375:Aging; D015897:Comorbidity; D019468:Disease Management; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D011379:Prognosis